Evidence map›Paper›PMID 32679312›Full record

ArticleNeurobiology of disease2020

Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration.

Ahmed Hasbi, Meenalochani Sivasubramanian, Marija Milenkovic, Kristina Komarek, Bertha K Madras, Susan R George

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. The Signaling and Pharmacology of the Dopamine D1 Receptor.Frontiers in cellular neuroscience · 2021
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. GPCR Heterodimers: Implications for Biased Signaling.Handbook of experimental pharmacology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
  16. Dopamine DBiomolecules · 2022
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ahmed HasbiDepartment of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: a.hasbi@utoronto.ca.
Meenalochani SivasubramanianDepartment of Pharmacology, University of Toronto, Toronto, ON, Canada.
Marija MilenkovicDepartment of Pharmacology, University of Toronto, Toronto, ON, Canada.
Kristina KomarekDepartment of Pharmacology, University of Toronto, Toronto, ON, Canada.
Bertha K MadrasDepartment of Psychiatry, Harvard Medical School, Boston and McLean Hospital, Belmont, MA, USA.
Susan R GeorgeDepartment of Pharmacology, University of Toronto, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: s.george@utoronto.ca.
University of Toronto · CA

Funding

Long Term THC Elicits Distinct Changes in Adolescent Brain Dopamine SignalingR01DA042178 · NIDA · MCLEAN HOSPITAL · PI MADRAS, BERTHA K · 2017 to 2021
$2.8M
CIHR PJT-148633NIDA NIH HHS R01 DA042178
6 · The paper itself

Abstract

backgroundDopamine receptors interact with other receptors to form heterooligomers. One such complex, the D1-D2 heteromer, demonstrated in cultured striatal neurons and rat striatum has been linked to drug addiction, Parkinson's disease, schizophrenia, depression and anhedonia.

methodsD1-D2 heteromer expression was evaluated using in situ proximity ligation assay, in parallel with cellular colocalization of D1 and D2 mRNA using in situ hybridization in 19 different key rat brain regions. Expression in higher species and changes in rat striatum after repeated cocaine administration were evaluated.

resultsDifferences in D1-D2 heteromer expression in striatal subregions are documented in higher species with nonhuman primate and human demonstrating higher density of heteromer-expressing neurons compared to rodents. All species had higher density of D1-D2 neurons in nucleus accumbens compared to dorsal striatum. Multiple other brain regions are identified where D1-D2 heteromer is expressed, prominently in cerebral cortical subregions including piriform, medial prefrontal, orbitofrontal and others; subcortical regions such as claustrum, amygdala and lateral habenula. Three categories of regions are identified: D1-D2 heteromer expressed despite little to no observed D1/D2 mRNA colocalization, likely representing heteromer on neuronal projections from other brain regions; D1-D2 heteromer originating locally with the density of neurons expressing heteromer matching neurons with colocalized D1/D2 mRNA; regions with both a local origin and targeted inputs projecting from other regions. Repeated cocaine administration significantly increased density of neurons expressing D1-D2 heteromer and D1/D2 mRNA colocalization in rat striatum, with changes in both direct and indirect pathway neurons.

conclusionThe dopamine D1-D2 heteromer is expressed in key brain cortical and subcortical regions of all species examined. Species differences in striatum revealed greater abundance in human>nonhuman-primate>rat>mouse, suggesting an evolutionary biologic role for the D1-D2 heteromer in higher CNS function. Its upregulation in rat striatum following cocaine points to regulatory significance with possible relevance for clinical disorders such as drug addiction. The dopamine D1-D2 receptor heteromer may represent a potential target for neuropsychiatric and neurodegenerative disorders, given its distribution in highly relevant brain regions.

Indexed as

AnimalsBrainCocaineCocaine-Related DisordersCorpus StriatumDopamine Uptake InhibitorsFemaleHumansMacaca mulattaMaleMiceNeuronsRatsRats, Sprague-DawleyReceptors, DopamineSpecies SpecificityCocaineDopamine Uptake InhibitorsReceptors, Dopaminebasal gangliacalcium signalingcocainedopaminedopamine receptorsdrug addictionreceptor heterodimerreceptor heteromer

Identifiers

PMID32679312
PMCPMC7450246
OpenAlexW3043601785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.